GGrantIndex
← Search

DEVELOPING RATIONALIZED THERAPEUTIC STRATEGY TO TARGET ADVANCED STAGE TRIPLE-NEGATIVE BREAST CANCER

$719,550FY2022Defense Health AgencyDOD

University Of Illinois

Investigators

View source on USAspending →
DEVELOPING RATIONALIZED THERAPEUTIC STRATEGY TO TARGET ADVANCED STAGE TRIPLE-NEGATIVE BREAST CANCER · GrantIndex